Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 1Thymoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1SCLC, Extensive Stage 1Resectable Esophageal Cancer 1Rectal Neoplasms 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Neoplasms 1NSCLC 1Mouth Neoplasms 1Lung Neoplasms 1Esophageal Squamous Cell Carcinoma 1Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

venetoclax 1tegafur-gimeracil-oteracil 1tagraxofusp 1Surgical Procedures, Operative 1Radiation 1Oxaliplatin 1Observation 1Neoadjuvant Therapy 1Magnetic Resonance Imaging 1Leucovorin 1Irinotecan 1Induction Chemotherapy 1Immunotherapy 1Immune Checkpoint Inhibitors 1Folfox protocol 1Fluorouracil 1FOLFOXIRI protocol 1Endoscopy 1Drug Therapy 1Colonoscopy 1Chemoradiotherapy 1Carboplatin 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pathologic Complete Response × Chemoradiotherapy × Clear all
NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting
394 enrolled

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡